AdaptHealth Corp. (NASDAQ:AHCO) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of AdaptHealth Corp. (NASDAQ:AHCO) have earned a consensus rating of “Moderate Buy” from the nine analysts that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and seven have issued a buy rating on the company. The average 1 year target price among analysts that have covered the stock in the last year is $10.2857.

Several analysts recently issued reports on the company. Robert W. Baird set a $10.00 price target on AdaptHealth in a report on Wednesday, August 5th. Truist Financial dropped their target price on AdaptHealth from $14.00 to $9.00 and set a “buy” rating on the stock in a research report on Wednesday, August 5th. Wall Street Zen lowered AdaptHealth from a “hold” rating to a “sell” rating in a research report on Sunday, August 16th. Canaccord Genuity Group set a $10.00 target price on AdaptHealth in a research note on Wednesday, August 5th. Finally, Royal Bank Of Canada reduced their price target on shares of AdaptHealth from $15.00 to $8.00 and set an “outperform” rating for the company in a report on Thursday, August 6th.

Insider Activity

In other AdaptHealth news, insider Russell E. Schuster III sold 11,275 shares of the company’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $10.06, for a total value of $113,426.50. Following the completion of the transaction, the insider owned 136,538 shares in the company, valued at approximately $1,373,572.28. This represents a 7.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Kenneth A. Samet purchased 23,500 shares of the company’s stock in a transaction on Thursday, August 6th. The stock was purchased at an average price of $6.38 per share, for a total transaction of $149,930.00. Following the purchase, the director directly owned 48,569 shares of the company’s stock, valued at $309,870.22. This trade represents a 93.74% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 1.95% of the company’s stock.

Hedge Funds Weigh In On AdaptHealth

Several hedge funds and other institutional investors have recently made changes to their positions in the business. PNC Financial Services Group Inc. grew its position in AdaptHealth by 22.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock valued at $70,000 after purchasing an additional 1,279 shares in the last quarter. MetLife Investment Management LLC increased its stake in AdaptHealth by 3.1% in the 4th quarter. MetLife Investment Management LLC now owns 57,364 shares of the company’s stock valued at $571,000 after buying an additional 1,749 shares during the period. Corient Private Wealth LLC lifted its position in AdaptHealth by 8.6% in the 4th quarter. Corient Private Wealth LLC now owns 22,562 shares of the company’s stock worth $227,000 after buying an additional 1,794 shares in the last quarter. Rockefeller Capital Management L.P. lifted its position in AdaptHealth by 433.0% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock worth $26,000 after buying an additional 2,100 shares in the last quarter. Finally, Assetmark Inc. boosted its stake in shares of AdaptHealth by 54.8% during the 1st quarter. Assetmark Inc. now owns 6,952 shares of the company’s stock valued at $83,000 after buying an additional 2,460 shares during the period. 82.67% of the stock is currently owned by institutional investors and hedge funds.

AdaptHealth Price Performance

AHCO opened at $5.48 on Wednesday. The firm has a market cap of $747.14 million, a price-to-earnings ratio of -3.20, a price-to-earnings-growth ratio of 0.29 and a beta of 1.47. AdaptHealth has a fifty-two week low of $5.21 and a fifty-two week high of $13.43. The company’s 50-day moving average price is $8.94 and its 200 day moving average price is $10.18. The company has a quick ratio of 0.98, a current ratio of 1.12 and a debt-to-equity ratio of 1.37.

AdaptHealth (NASDAQ:AHCO) last issued its earnings results on Tuesday, August 4th. The company reported ($0.99) EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($1.16). The company had revenue of $740.31 million during the quarter, compared to analyst estimates of $846.77 million. AdaptHealth had a negative net margin of 7.07% and a positive return on equity of 3.36%. The business’s revenue was down 7.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.10 earnings per share. As a group, sell-side analysts expect that AdaptHealth will post 0.44 earnings per share for the current year.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.